Industry: Chemical & Material
Published Date: 2024-09-25
Pages: 108 Pages
Report ld: 3329791
Request Sample
Customized Report
Erythromycin Thiocyanate API Market Size(US$)

CAGR 2024-2030
5.5%
Market Size,2030
USD 2,274
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
The global Erythromycin Thiocyanate API revenue was US$ 1571 million in 2023 and is forecast to a readjusted size of US$ 2274 million by 2030 with a CAGR of 5.5% during the review period (2024-2030).
In United States the Erythromycin Thiocyanate API revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).
This report focuses on global and United States Erythromycin Thiocyanate API market, also covers the segmentation data of other regions in regional level and county level.
The global key players of Erythromycin Thiocyanate API include Yili Chuannig Biotechnology, Yichang East Sunshine, Alebi Pharma, META Pharmaceuticals, Anuh Pharma, HEC Group, AbbVie, etc. The global five biggest players hold a share of % in 2023.
Erythromycin Thiocyanate API market is segmented in regional and country level, by players, by Type, and by Application. Companies, stakeholders, and other participants in the global Erythromycin Thiocyanate API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2019-2030.
For United States market, this report focuses on the Erythromycin Thiocyanate API market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces Erythromycin Thiocyanate API definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Erythromycin Thiocyanate API companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue and volume of Erythromycin Thiocyanate API in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6: Americas by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Erythromycin Thiocyanate API sales, revenue, gross margin, and recent development, etc.
Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12: research findings and conclusion
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Erythromycin Thiocyanate API Product Introduction
1.2 Global Erythromycin Thiocyanate API Outlook 2019 VS 2023 VS 2030
1.2.1 Global Erythromycin Thiocyanate API Sales in US$ Million for the Year 2019-2030
1.2.2 Global Erythromycin Thiocyanate API Sales in Volume for the Year 2019-2030
1.3 United States Erythromycin Thiocyanate API Outlook 2019 VS 2023 VS 2030
1.3.1 United States Erythromycin Thiocyanate API Sales in US$ Million for the Year 2019-2030
1.3.2 United States Erythromycin Thiocyanate API Sales in Volume for the Year 2019-2030
1.4 Erythromycin Thiocyanate API Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.4.1 The Market Share of United States Erythromycin Thiocyanate API in Global, 2019 VS 2023 VS 2030
1.4.2 The Growth Rate of Erythromycin Thiocyanate API Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.5 Erythromycin Thiocyanate API Market Dynamics
1.5.1 Erythromycin Thiocyanate API Industry Trends
1.5.2 Erythromycin Thiocyanate API Market Drivers
1.5.3 Erythromycin Thiocyanate API Market Challenges
1.5.4 Erythromycin Thiocyanate API Market Restraints
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Erythromycin Thiocyanate API by Type
2.1 Erythromycin Thiocyanate API Market by Type
2.1.1 Industrial Grade
2.1.2 Feed Grade
2.1.3 Pharmaceutical Grade
2.2 Global Erythromycin Thiocyanate API Market Size by Type
2.2.1 Global Erythromycin Thiocyanate API Sales in Value, by Type (2019, 2023 & 2030)
2.2.2 Global Erythromycin Thiocyanate API Sales in Volume, by Type (2019, 2023 & 2030)
2.2.3 Global Erythromycin Thiocyanate API Average Selling Price (ASP) by Type (2019, 2023 & 2030)
2.3 United States Erythromycin Thiocyanate API Market Size by Type
2.3.1 United States Erythromycin Thiocyanate API Sales in Value, by Type (2019, 2023 & 2030)
2.3.2 United States Erythromycin Thiocyanate API Sales in Volume, by Type (2019, 2023 & 2030)
2.3.3 United States Erythromycin Thiocyanate API Average Selling Price (ASP) by Type (2019, 2023 & 2030)
3 Erythromycin Thiocyanate API by Application
3.1 Erythromycin Thiocyanate API Market by Application
3.1.1 Erythromycin Synthesis
3.1.2 Feed Additive
3.2 Global Erythromycin Thiocyanate API Market Size by Application
3.2.1 Global Erythromycin Thiocyanate API Sales in Value, by Application (2019, 2023 & 2030)
3.2.2 Global Erythromycin Thiocyanate API Sales in Volume, by Application (2019, 2023 & 2030)
3.2.3 Global Erythromycin Thiocyanate API Average Selling Price (ASP) by Application (2019, 2023 & 2030)
3.3 United States Erythromycin Thiocyanate API Market Size by Application
3.3.1 United States Erythromycin Thiocyanate API Sales in Value, by Application (2019, 2023 & 2030)
3.3.2 United States Erythromycin Thiocyanate API Sales in Volume, by Application (2019, 2023 & 2030)
3.3.3 United States Erythromycin Thiocyanate API Average Selling Price (ASP) by Application (2019, 2023 & 2030)
4 Global Erythromycin Thiocyanate API Competitor Landscape by Company
4.1 Global Erythromycin Thiocyanate API Market Size by Company
4.1.1 Global Key Manufacturers of Erythromycin Thiocyanate API, Ranked by Revenue (2023)
4.1.2 Global Erythromycin Thiocyanate API Revenue by Manufacturer (2019-2024)
4.1.3 Global Erythromycin Thiocyanate API Sales by Manufacturer (2019-2024)
4.1.4 Global Erythromycin Thiocyanate API Price by Manufacturer (2019-2024)
4.2 Global Erythromycin Thiocyanate API Concentration Ratio (CR)
4.2.1 Erythromycin Thiocyanate API Market Concentration Ratio (CR) (2019-2024)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Erythromycin Thiocyanate API in 2023
4.2.3 Global Erythromycin Thiocyanate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Erythromycin Thiocyanate API, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Erythromycin Thiocyanate API, Product Offered and Application
4.5 Global Key Manufacturers of Erythromycin Thiocyanate API, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 United States Erythromycin Thiocyanate API Market Size by Company
4.7.1 Key Players of Erythromycin Thiocyanate API in United States, Ranked by Revenue (2023)
4.7.2 United States Erythromycin Thiocyanate API Revenue by Players (2019-2024)
4.7.3 United States Erythromycin Thiocyanate API Sales by Players (2019-2024)
5 Global Erythromycin Thiocyanate API Market Size by Region
5.1 Global Erythromycin Thiocyanate API Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Erythromycin Thiocyanate API Market Size in Volume by Region (2019-2030)
5.2.1 Global Erythromycin Thiocyanate API Sales in Volume by Region: 2019-2024
5.2.2 Global Erythromycin Thiocyanate API Sales in Volume Forecast by Region (2025-2030)
5.3 Global Erythromycin Thiocyanate API Market Size in Value by Region (2019-2030)
5.3.1 Global Erythromycin Thiocyanate API Sales in Value by Region: 2019-2024
5.3.2 Global Erythromycin Thiocyanate API Sales in Value by Region: 2025-2030
6 Americas
6.1 Americas Erythromycin Thiocyanate API Market Size YoY Growth 2019-2030
6.2 Americas Erythromycin Thiocyanate API Sales in Volume, by Type (2019, 2023 & 2030)
6.3 Americas Erythromycin Thiocyanate API Sales in Volume, by Application (2019, 2023 & 2030)
6.4 Americas Erythromycin Thiocyanate API Market Facts & Figures by Country (2019, 2023 & 2030)
6.4.1 Americas Erythromycin Thiocyanate API Sales in Value by Country (2019, 2023 & 2030)
6.4.2 Americas Erythromycin Thiocyanate API Sales in Volume by Country (2019, 2023 & 2030)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Erythromycin Thiocyanate API Market Size YoY Growth 2019-2030
7.2 EMEA Erythromycin Thiocyanate API Sales in Volume, by Type (2019, 2023 & 2030)
7.3 EMEA Erythromycin Thiocyanate API Sales in Volume, by Application (2019, 2023 & 2030)
7.4 EMEA Erythromycin Thiocyanate API Market Facts & Figures by Country (2019, 2023 & 2030)
7.4.1 EMEA Erythromycin Thiocyanate API Sales in Value by Country (2019, 2023 & 2030)
7.4.2 EMEA Erythromycin Thiocyanate API Sales in Volume by Country (2019, 2023 & 2030)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Erythromycin Thiocyanate API Market Size YoY Growth 2019-2030
8.2 China Erythromycin Thiocyanate API Sales in Volume, by Type (2019, 2023 & 2030)
8.3 China Erythromycin Thiocyanate API Sales in Volume, by Application (2019, 2023 & 2030)
9 APAC
9.1 APAC Erythromycin Thiocyanate API Market Size YoY Growth 2019-2030
9.2 APAC Erythromycin Thiocyanate API Sales in Volume, by Type (2019, 2023 & 2030)
9.3 APAC Erythromycin Thiocyanate API Sales in Volume, by Application (2019, 2023 & 2030)
9.4 APAC Erythromycin Thiocyanate API Market Facts & Figures by Country (2019, 2023 & 2030)
9.4.1 APAC Erythromycin Thiocyanate API Sales in Value by Country (2019, 2023 & 2030)
9.4.2 APAC Erythromycin Thiocyanate API Sales in Volume by Country (2019, 2023 & 2030)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Yili Chuannig Biotechnology
10.1.1 Yili Chuannig Biotechnology Company Information
10.1.2 Yili Chuannig Biotechnology Description and Business Overview
10.1.3 Yili Chuannig Biotechnology Erythromycin Thiocyanate API Sales, Revenue and Gross Margin (2019-2024)
10.1.4 Yili Chuannig Biotechnology Erythromycin Thiocyanate API Products Offered
10.1.5 Yili Chuannig Biotechnology Recent Development
10.2 Yichang East Sunshine
10.2.1 Yichang East Sunshine Company Information
10.2.2 Yichang East Sunshine Description and Business Overview
10.2.3 Yichang East Sunshine Erythromycin Thiocyanate API Sales, Revenue and Gross Margin (2019-2024)
10.2.4 Yichang East Sunshine Erythromycin Thiocyanate API Products Offered
10.2.5 Yichang East Sunshine Recent Development
10.3 Alebi Pharma
10.3.1 Alebi Pharma Company Information
10.3.2 Alebi Pharma Description and Business Overview
10.3.3 Alebi Pharma Erythromycin Thiocyanate API Sales, Revenue and Gross Margin (2019-2024)
10.3.4 Alebi Pharma Erythromycin Thiocyanate API Products Offered
10.3.5 Alebi Pharma Recent Development
10.4 META Pharmaceuticals
10.4.1 META Pharmaceuticals Company Information
10.4.2 META Pharmaceuticals Description and Business Overview
10.4.3 META Pharmaceuticals Erythromycin Thiocyanate API Sales, Revenue and Gross Margin (2019-2024)
10.4.4 META Pharmaceuticals Erythromycin Thiocyanate API Products Offered
10.4.5 META Pharmaceuticals Recent Development
10.5 Anuh Pharma
10.5.1 Anuh Pharma Company Information
10.5.2 Anuh Pharma Description and Business Overview
10.5.3 Anuh Pharma Erythromycin Thiocyanate API Sales, Revenue and Gross Margin (2019-2024)
10.5.4 Anuh Pharma Erythromycin Thiocyanate API Products Offered
10.5.5 Anuh Pharma Recent Development
10.6 HEC Group
10.6.1 HEC Group Company Information
10.6.2 HEC Group Description and Business Overview
10.6.3 HEC Group Erythromycin Thiocyanate API Sales, Revenue and Gross Margin (2019-2024)
10.6.4 HEC Group Erythromycin Thiocyanate API Products Offered
10.6.5 HEC Group Recent Development
10.7 AbbVie
10.7.1 AbbVie Company Information
10.7.2 AbbVie Description and Business Overview
10.7.3 AbbVie Erythromycin Thiocyanate API Sales, Revenue and Gross Margin (2019-2024)
10.7.4 AbbVie Erythromycin Thiocyanate API Products Offered
10.7.5 AbbVie Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Erythromycin Thiocyanate API Industry Chain Analysis
11.2 Erythromycin Thiocyanate API Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Erythromycin Thiocyanate API Production Mode & Process
11.4 Erythromycin Thiocyanate API Sales and Marketing
11.4.1 Erythromycin Thiocyanate API Sales Channels
11.4.2 Erythromycin Thiocyanate API Distributors
11.5 Erythromycin Thiocyanate API Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Erythromycin Thiocyanate API market is projected to grow from US$ 1731 million in 2025 to US$ 2505 million by 2032, at a CAGR of 5.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 143
USD 4900.00
(Single User License)
The global Erythromycin Thiocyanate API market size was US$ 1731 million in 2025 and is forecast to reach a readjusted size of US$ 2505 million by 2032 with a CAGR of 5.5% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 77
USD 4250.00
(Single User License)
The global market for Erythromycin Thiocyanate API was estimated to be worth US$ 1731 million in 2025 and is projected to reach US$ 2505 million, growing at a CAGR of 5.5% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 95
USD 3950.00
(Single User License)
The global Erythromycin Thiocyanate API market was valued at US$ 1731 million in 2025 and is anticipated to reach US$ 2505 million by 2032, at a CAGR of 5.5% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 129
USD 2900.00
(Single User License)
The global Erythromycin Thiocyanate API market is projected to grow from US$ 1649 million in 2024 to US$ 2387 million by 2031, at a CAGR of 5.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 145
USD 4900.00
(Single User License)
The global Erythromycin Thiocyanate API market size was US$ 1649 million in 2024 and is forecast to a readjusted size of US$ 2387 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 78
USD 4250.00
(Single User License)
The global market for Erythromycin Thiocyanate API was estimated to be worth US$ 1649 million in 2024 and is forecast to a readjusted size of US$ 2387 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 95
USD 3950.00
(Single User License)
The global market for Erythromycin Thiocyanate API was valued at US$ 1649 million in the year 2024 and is projected to reach a revised size of US$ 2387 million by 2031, growing at a CAGR of 5.5% during the forecast period.
Published Date: 2025-03-10
Pages: 89
USD 2900.00
(Single User License)
Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
Published Date: 2024-09-25
Pages: 91
USD 2900.00
(Single User License)
Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
Published Date: 2024-09-25
Pages: 137
USD 4900.00
(Single User License)
The global Erythromycin Thiocyanate API market is projected to grow from US$ 1731 million in 2025 to US$ 2505 million by 2032, at a CAGR of 5.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 143
The global Erythromycin Thiocyanate API market size was US$ 1731 million in 2025 and is forecast to reach a readjusted size of US$ 2505 million by 2032 with a CAGR of 5.5% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 77
The global market for Erythromycin Thiocyanate API was estimated to be worth US$ 1731 million in 2025 and is projected to reach US$ 2505 million, growing at a CAGR of 5.5% from 2026 to 2032.
Published: 2026-01-09
Pages: 95
The global Erythromycin Thiocyanate API market was valued at US$ 1731 million in 2025 and is anticipated to reach US$ 2505 million by 2032, at a CAGR of 5.5% from 2026 to 2032.
Published: 2026-01-09
Pages: 129
The global Erythromycin Thiocyanate API market is projected to grow from US$ 1649 million in 2024 to US$ 2387 million by 2031, at a CAGR of 5.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 145
The global Erythromycin Thiocyanate API market size was US$ 1649 million in 2024 and is forecast to a readjusted size of US$ 2387 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 78
The global market for Erythromycin Thiocyanate API was estimated to be worth US$ 1649 million in 2024 and is forecast to a readjusted size of US$ 2387 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 95
The global market for Erythromycin Thiocyanate API was valued at US$ 1649 million in the year 2024 and is projected to reach a revised size of US$ 2387 million by 2031, growing at a CAGR of 5.5% during the forecast period.
Published: 2025-03-10
Pages: 89
Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
Published: 2024-09-25
Pages: 91
Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
Published: 2024-09-25
Pages: 137
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now